Effectiveness of interventions for the reversal of a metabolic syndrome diagnosis: An update of a meta-analysis of mixed treatment comparison studies
- PMID: 31860177
- PMCID: PMC7363343
- DOI: 10.7705/biomedica.4684
Effectiveness of interventions for the reversal of a metabolic syndrome diagnosis: An update of a meta-analysis of mixed treatment comparison studies
Abstract
Introduction: Identifying the most effective interventions to reverse the metabolic syndrome can be key in the design of clinical strategies to prevent progression to type 2 diabetes mellitus and cardiovascular disease. Objective: To estimate the effect size of the interventions used for the reversal of metabolic syndrome. Materials and methods: We searched in Embase and Medline databases for randomized clinical trials with an outcome defined as the reversal of the metabolic syndrome diagnosis. We classified the interventions in four dimensions: 1) lifestyle (diet and exercise); 2) pharmaceuticals; 3) a combination of both, and 4) control groups, and we conducted a mixed treatment comparison analysis. Results: Additional to the previous meta-analysis published by Dunkley, et al. in 2012, we dentified two other studies. Lifestyle interventions had 2.61 more chances to achieve the reversal of the metabolic syndrome than the control group, with a credible interval between 1.00 and 5.47. Pharmaceutical treatments showed a 3.39 higher chance of reversing the syndrome compared with the control group, but the credible interval was estimated from 0.81 to 9.99. Lifestyle interventions had 1.59 more chance of reversal than the pharmaceutical treatments. Conclusion: Diet and physical activity-based interventions had a higher probability of effectiveness to reverse a metabolic syndrome diagnosis.
Introducción. El conocer las intervenciones más efectivas para revertir el síndrome metabólico es clave para el diseño de estrategias clínicas de prevención de enfermedades como la diabetes mellitus de tipo 2 y la enfermedad cardiovascular. Objetivo. Sintetizar el tamaño del efecto de las intervenciones disponibles para revertir un diagnóstico de síndrome metabólico. Materiales y métodos. Se hizo la búsqueda en Embase y Medline, incluyendo los ensayos clínicos en los que la variable "respuesta" se definía como la reversión del diagnóstico del síndrome metabólico. Se categorizaron las intervenciones en cuatro dimensiones: 1) estilo de vida (dieta y ejercicio); 2) farmacia; 3) combinación de estilo de vida y farmacia, y 4) grupos de control; finalmente, se hizo una comparación mixta de tratamientos. Resultados. Se detectaron dos estudios adicionales a los incluidos en el metaanálisis publicado por Dunkley, et al., en el 2012. Se estimó que las intervenciones relacionadas con el estilo de vida tuvieron 2,61 veces (intervalo de credibilidad entre 1,00 y 5,47) más probabilidades de revertir el síndrome metabólico que las de los grupos de control y las relacionadas con los tratamientos farmacéuticos, una probabilidad de 3,39 veces más que las del grupo de control, pero con un intervalo de credibilidad entre 0,81 y 9,99. Las intervenciones sobre el estilo de vida tuvieron 1,59 veces más probabilidades de revertir el síndrome metabólico que las del tratamiento farmacéutico. Conclusión. Las estrategias basadas en la dieta y la actividad física de las personas, tuvieron una mayor probabilidad de ser más efectivas para revertir el diagnóstico de síndrome metabólico.
Keywords: Metabolic syndrome; diabetes mellitus; type 2; cardiovascular diseases; metaanalysis; odds ratio.
Conflict of interest statement
Figures



Similar articles
-
The effect of weight management interventions that include a diet component on weight-related outcomes in pregnant and postpartum women: a systematic review protocol.JBI Database System Rev Implement Rep. 2015 Jan;13(1):88-98. doi: 10.11124/jbisrir-2015-1812. JBI Database System Rev Implement Rep. 2015. PMID: 26447010
-
Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.Am J Cardiovasc Drugs. 2005;5(6):379-87. doi: 10.2165/00129784-200505060-00005. Am J Cardiovasc Drugs. 2005. PMID: 16259526 Review.
-
Systematization of clinical trials related to treatment of metabolic syndrome, 1980-2015.Endocrinol Diabetes Nutr. 2017 Feb;64(2):82-91. doi: 10.1016/j.endinu.2016.09.002. Epub 2017 Feb 4. Endocrinol Diabetes Nutr. 2017. PMID: 28440782 English, Spanish.
-
Aggressively preventing diabetes.Nat Rev Nephrol. 2010 Jun;6(6):313. doi: 10.1038/nrneph.2010.63. Nat Rev Nephrol. 2010. PMID: 20508667 No abstract available.
-
Management of hypertension in children and adolescents with the metabolic syndrome.J Cardiometab Syndr. 2006 Summer;1(4):259-68. doi: 10.1111/j.1559-4564.2006.05801.x. J Cardiometab Syndr. 2006. PMID: 17679805 Review.
Cited by
-
Enhancing intestinal barrier efficiency: A novel metabolic diseases therapy.Front Nutr. 2023 Mar 2;10:1120168. doi: 10.3389/fnut.2023.1120168. eCollection 2023. Front Nutr. 2023. PMID: 36937361 Free PMC article. Review.
-
Desired weight loss and its association with health, health behaviors and perceptions in an adult population with weight excess: One-year follow-up.Front Nutr. 2022 Jul 22;9:848055. doi: 10.3389/fnut.2022.848055. eCollection 2022. Front Nutr. 2022. PMID: 35938116 Free PMC article.
-
Effect of a Community Gerontology Program on the Control of Metabolic Syndrome in Mexican Older Adults.Healthcare (Basel). 2022 Mar 2;10(3):466. doi: 10.3390/healthcare10030466. Healthcare (Basel). 2022. PMID: 35326944 Free PMC article.
-
Effect of intermittent fasting on obesity and metabolic indices in patients with metabolic syndrome: a systematic review and meta analysis.BMC Endocr Disord. 2025 May 14;25(1):130. doi: 10.1186/s12902-025-01952-x. BMC Endocr Disord. 2025. PMID: 40369509 Free PMC article.
-
Causal association study of the dynamic development of the metabolic syndrome based on longitudinal data.Sci Rep. 2024 Mar 5;14(1):5448. doi: 10.1038/s41598-024-55693-3. Sci Rep. 2024. PMID: 38443462 Free PMC article.
References
-
- Balkau B, Charles MA, Drivsholm T, Borch-Johnsen K, Wareham N, Yudkin JS, et al. Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabet Metab. 2002;28:364–376. - PubMed
-
- Aguilar-Salinas CA, Rojas R, Gómez-Pérez FJ, Valles V, Ríos-Torres JM, Franco A, et al. Analysis of the agreement between the World Health Organization criteria and the National Cholesterol Education Program-III definition of the metabolic syndrome: results from a population-based survey. Diabetes Care. 2003;26:1635–1635. doi: 10.2337/diacare.26.5.1635. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical